Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled Trials

Authors:
  • AAAntimicrobial Availability Task Force Of The Infectious Diseases Society Of America
    Antimicrobial Availability Task Force Of The Infectious Diseases Society Of America

Abstract
Background. The United States Food and Drug Administration requires clinical trial noninferiority margins to preserve a fraction (eg, 50%) of the est

This publication has 54 references indexed in Scilit: